Decibel Therapeutics, Inc. Common Stock
DBTX
DBTX was delisted on the 22nd of September, 2023.
1 hedge funds and large institutions have $36.4K invested in Decibel Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 36 closing their positions.
83% more call options, than puts
Call options by funds: $11K | Put options by funds: $6K
97% less funds holding
Funds holding: 37 → 1 (-36)
100% less capital invested
Capital invested by funds: $59.2M → $36.4K (-$59.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Atlas Capital Advisors
Jackson,
Wyoming
|
+$63K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$19M |
| 2 |
TGI
TRV GP III
Boston,
Massachusetts
|
-$12.1M |
| 3 |
BlackRock
New York
|
-$6.97M |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
-$6.3M |
| 5 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$3.09M |
DBTX Hedge Fund Activity: Q3 2023 in Review
1 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Decibel Therapeutics, Inc. Common Stock (DBTX) for Q3 2023, worth a combined $36.4K — down 100% from $59.2M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of DBTX and 0 opened new positions — a net loss of 36 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Atlas Capital Advisors, adding an estimated $63K. The largest seller was OrbiMed, exiting entirely with an estimated $19M sold.
- 1 institutional investor held Decibel Therapeutics, Inc. Common Stock (DBTX) as of Q3 2023, down from 37 in Q2 2023.
- Funds reported $36.4K of Decibel Therapeutics, Inc. Common Stock stock for Q3 2023, down 100% quarter-over-quarter.
- 0 funds opened new Decibel Therapeutics, Inc. Common Stock positions in Q3 2023 and 36 closed out, a net change of -36 holders.
- The largest Decibel Therapeutics, Inc. Common Stock buyer in Q3 2023 was Atlas Capital Advisors, an estimated $63K added.
- The largest Decibel Therapeutics, Inc. Common Stock seller in Q3 2023 was OrbiMed, an estimated $19M sold.
Based on aggregated 13F filings for Q3 2023.